Open Access

[Corrigendum] miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway

  • Authors:
    • Shaohua Xiang
    • Jing Li
    • Zhengfu Zhang
  • View Affiliations

  • Published online on: October 29, 2020     https://doi.org/10.3892/etm.2020.9412
  • Article Number: 282
  • Copyright : © Xiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

December-2020
Volume 20 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xiang S, Li J and Zhang Z: [Corrigendum] miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway. Exp Ther Med 20: 282, 2020
APA
Xiang, S., Li, J., & Zhang, Z. (2020). [Corrigendum] miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway. Experimental and Therapeutic Medicine, 20, 282. https://doi.org/10.3892/etm.2020.9412
MLA
Xiang, S., Li, J., Zhang, Z."[Corrigendum] miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway". Experimental and Therapeutic Medicine 20.6 (2020): 282.
Chicago
Xiang, S., Li, J., Zhang, Z."[Corrigendum] miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway". Experimental and Therapeutic Medicine 20, no. 6 (2020): 282. https://doi.org/10.3892/etm.2020.9412